DGCI gives approval for human clinical trials of COVAXIN, first potential COVID-19 Vaccine developed in the country

June 30, 2020 1:53 PM

DGCI gives approval for human clinical trials of COVAXIN, first potential COVID-19 Vaccine developed in the country

<span style="color: #222222;">The Central Drug Standard Control Organisation, the National regulatory body for Indian Pharmaceuticals and medical devices, has granted approval to Bharat Biotech India to conduct human clinical trials for Corona Vaccine called 'Covaxin'. The company in a statement said it is the first indigenous COVID-19 vaccine to receive the approval. The Covaxin has been developed in collaboration with the Indian Council of Medical Research (ICMR) and National I...

DGCI gives approval for human clinical trials of COVAXIN, first potential COVID-19 Vaccine developed in the country

June 30, 2020 1:53 PM

DGCI gives approval for human clinical trials of COVAXIN, first potential COVID-19 Vaccine developed in the country

<span style="color: #222222;">The Central Drug Standard Control Organisation, the National regulatory body for Indian Pharmaceuticals and medical devices, has granted approval to Bharat Biotech India to conduct human clinical trials for Corona Vaccine called 'Covaxin'. The company in a statement said it is the first indigenous COVID-19 vaccine to receive the approval. The Covaxin has been developed in collaboration with the Indian Council of Medical Research (ICMR) and National I...